Minimizing Collateral Damage from COVD-19 Distancing Strategies: Protecting Patients who have Multi-Morbidity

IF 1.6 4区医学 Q3 PRIMARY HEALTH CARE Primary Health Care Research and Development Pub Date : 2020-01-01 DOI:10.15761/HPC.1000200

E. Shadmi, C. Boult, R. Balicer

引用次数: 0

Abstract

Most epidemiologic models project that only a small fraction of the world’s billion people who have “multi-morbidity” (i.e., three or more chronic health conditions) [1] will succumb to COVID-19-induced mortality. Many more multi-morbid people, most of whom are older, are vulnerable to incurring “collateral damage,” i.e., deterioration and death as a result of “social-distancing” and other pandemic control strategies that are likely to continue until a vaccine becomes widely available (in mid-2021 at the earliest) [2].

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

尽量减少covid -19隔离策略的附带损害:保护多重发病患者

大多数流行病学模型预测，在世界上10亿患有“多重疾病”(即三种或三种以上慢性健康状况)[1]的人中，只有一小部分人会死于covid -19引起的死亡。更多的多重疾病患者(其中大多数是老年人)很容易遭受“附带损害”，即由于“社交距离”和其他大流行控制策略而导致病情恶化和死亡，这些策略可能会持续到疫苗广泛获得(最早在2021年中期)[2]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Primary Health Care Research and Development PRIMARY HEALTH CARE-

CiteScore

2.60

自引率

6.20%

发文量

119

审稿时长

33 weeks

期刊介绍： Primary Health Care Research & Development is aimed specifically at both researchers and practitioners in primary health care, bridging the gap between the two areas. It provides a forum for the publication of international, interdisciplinary research and development in primary health care. It is essential reading for all involved in primary care: nurse practitioners, GPs and health service managers; professional and local groups in community health; researchers and academics; purchasers of primary health care services; allied health practitioners in secondary services and health-related consumer groups.